Ja. Ohar et al., CHRONIC PLATELET-ACTIVATING-FACTOR INDUCES A DECREASE IN PULMONARY VASCULAR COMPLIANCE, HYDROXYPROLINE, AND LOSS OF VASCULAR MATRIX, American journal of respiratory and critical care medicine, 149(6), 1994, pp. 1628-1634
Citations number
24
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
We have previously demonstrated that chronic intravenous platelet-acti
vating factor (PAF) induces morphologic remodeling of pulmonary arteri
es characterized by a decrease in internat and external elastic lamina
circumference, pulmonary arterial contracture, and internal elastic l
amina duplication. The mechanism of PAF-induced arterial contracture i
s unknown. In this study we determined whether PAF caused arterial con
tracture through cell loss by calculating the number of cell nuclei/to
tal cross-sectional area of arteries. The nuclear ratio was increased
in intra- and preacinar pulmonary arteries of PAF-treated rabbits. Hyd
roxyproline content of lungs stratified by anatomic region was signifi
cantly reduced in intra-acinar tissue of PAF-treated rabbits, indicati
ng that PAF-induced vascular contracture was associated with toss of i
nterstitial collagen. We next tested whether these morphologic alterat
ions were associated with decreased pulmonary vascular compliance and
increased resistance. Compliance and resistance were determined in iso
lated, perfused lungs from rabbits chronically treated with PAF. Compl
iance was calculated: (1) from the slope of the venous occlusion trace
(CVO), (2) by increasing left atrial pressure (CLA), (3) by increasin
g flow (CHF), and (4) by the classic static technique (CAV) Of adding
volume (2 mi) to a passively drained lung. Vascular compliance was sig
nificantly reduced in PAF-treated lungs when measured by all four meth
ods; however, pulmonary vascular resistance was unchanged. We conclude
that structural changes that result from chronic intravenous PAF infu
sion affect the elastic modulus to a greater extent than factors that
influence pulmonary vascular resistance.